Financial results - HIPPOCRATES CONSULTMED 2016 SRL

Financial Summary - Hippocrates Consultmed 2016 Srl
Unique identification code: 35493386
Registration number: J04/110/2016
Nace: 8622
Sales - Ron
190.199
Net Profit - Ron
179.384
Employee
1
The most important financial indicators for the company Hippocrates Consultmed 2016 Srl - Unique Identification Number 35493386: sales in 2023 was 190.199 euro, registering a net profit of 179.384 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Hippocrates Consultmed 2016 Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 20.374 35.518 52.228 54.911 66.254 112.060 147.968 190.199
Total Income - EUR - - 20.374 35.524 52.350 54.939 66.260 112.109 147.968 190.199
Total Expenses - EUR - - 1.452 919 644 322 634 1.612 583 8.950
Gross Profit/Loss - EUR - - 18.922 34.605 51.706 54.617 65.626 110.497 147.384 181.248
Net Profit/Loss - EUR - - 18.311 33.539 50.136 52.969 63.769 107.201 143.819 179.384
Employees - - 0 0 0 0 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 28.9%, from 147.968 euro in the year 2022, to 190.199 euro in 2023. The Net Profit increased by 36.001 euro, from 143.819 euro in 2022, to 179.384 in the last year.

Check the financial reports for the company - Hippocrates Consultmed 2016 Srl

Rating financiar

Financial Rating -
Hippocrates Consultmed 2016 Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Hippocrates Consultmed 2016 Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Hippocrates Consultmed 2016 Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Hippocrates Consultmed 2016 Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Hippocrates Consultmed 2016 Srl - CUI 35493386

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 18 0 0 0 0 0 0 0
Current Assets - - 18.623 33.908 50.608 53.461 64.495 108.195 144.258 180.611
Inventories - - 0 0 0 0 0 0 0 0
Receivables - - 0 0 0 38.660 41.347 46.495 104.228 128.778
Cash - - 18.623 6.368 10.078 9.754 18.197 61.700 40.030 51.833
Shareholders Funds - - 18.356 33.592 50.187 53.019 63.819 107.250 143.868 179.433
Social Capital - - 45 44 43 42 41 40 41 40
Debts - - 286 317 421 442 676 945 390 1.178
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 180.611 euro in 2023 which includes Inventories of 0 euro, Receivables of 128.778 euro and cash availability of 51.833 euro.
The company's Equity was valued at 179.433 euro, while total Liabilities amounted to 1.178 euro. Equity increased by 36.001 euro, from 143.868 euro in 2022, to 179.433 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Hippocrates Consultmed 2016 Srl

Comments - Hippocrates Consultmed 2016 Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.